These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1972580)

  • 1. LY 171555-induced catalepsy and defensive behavior in four strains of mice suggest the involvement of different D2 dopamine receptor systems.
    Puglisi-Allegra S; Carletti P; Cabib S
    Pharmacol Biochem Behav; 1990 Jun; 36(2):327-31. PubMed ID: 1972580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S; Cabib S
    Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist.
    Meller E; Kuga S; Friedhoff AJ; Goldstein M
    Life Sci; 1985 May; 36(19):1857-64. PubMed ID: 3157851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.
    Rosenzweig-Lipson S; Barrett JE
    Pharmacol Biochem Behav; 1995 Aug; 51(4):843-8. PubMed ID: 7675867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-dependent modulation of LY 171555-induced defensive behavior in the mouse.
    Cabib S; Puglisi-Allegra S
    Psychopharmacology (Berl); 1989; 97(2):166-8. PubMed ID: 2498923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes].
    Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY 171555-induced hyperdefensiveness in the mouse does not implicate benzodiazepine receptors.
    Belzung C; Cabib S; Fabiani L; Tolentino P; Puglisi-Allegra S
    Psychopharmacology (Berl); 1991; 103(4):449-54. PubMed ID: 1676525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.
    Kanes SJ; Hitzemann BA; Hitzemann RJ
    J Pharmacol Exp Ther; 1993 Oct; 267(1):538-47. PubMed ID: 7901398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the genes for haloperidol-induced catalepsy.
    Kanes S; Dains K; Cipp L; Gatley J; Hitzemann B; Rasmussen E; Sanderson S; Silverman M; Hitzemann R
    J Pharmacol Exp Ther; 1996 May; 277(2):1016-25. PubMed ID: 8627512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
    Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triazolam blocks the initial rotational effects of quinpirole but permits the later developing reduction of dopamine D2-mediated rotational behavior and dopamine D2 receptors.
    Zhou LW; Zhang SP; Welsh S; Connell TA; Weiss B
    Eur J Pharmacol; 1992 Aug; 218(2-3):219-27. PubMed ID: 1358635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.